The Asia-Pacific nanomedicines market is projected to grow at a modest CAGR of 10.9% during the forecast period (2021-2027). The major aspect that drives the growth of the market includes the rise in the prevalence of life-threatening diseases along with the demand for effective treatment solutions. Besides, the rapid development of healthcare infrastructure and growth […]
Category Archives: Pharmaceuticals
Global cancer treatment market is expected to grow at a CAGR of 4.9% during the forecast period. Growing incidence of cancer is boosting the demand for cancer treatment such as chemotherapy and radiation therapy. The most common type of cancer on the list is breast cancer, with 284,200 new cases expected in the US in […]
Global cancer treatment market is expected to grow at a CAGR of 4.9% during the forecast period. Growing incidence of cancer is boosting the demand for cancer treatment such as chemotherapy and radiation therapy. The most common type of cancer on the list is breast cancer, with 284,200 new cases expected in the US in […]
The global metabolic disorder therapeutics market is estimated to grow at a CAGR of 7.8% during the forecast period. An increasing number of clinical trials have been witnessed over the years owing to the rising prevalence of metabolic disorders and increasing demand for more effective treatment. For instance, in May 2020, POXEL SA, a biopharmaceutical […]
The global cancer monoclonal antibodies market is estimated to grow at a CAGR of 9.8% during the forecast period. Significant research on monoclonal antibodies have been witnessed, which is providing a scope for the market growth. The availability of funding and the increasing focus of researchers and biopharmaceutical firms towards the development of monoclonal antibodies […]
China cancer monoclonal antibodies market is estimated to grow at a CAGR of 11.6% during the forecast period. An increasing launch of biosimilars has been witnessed in the country owing to the increasing focus on providing affordable cancer therapy in the country. For instance, in August 2020, China’s NMPA (National Medical Products Administration) approved a […]
Asia-Pacific cancer monoclonal antibodies market is estimated to grow at a CAGR of 11.2% during the forecast period. Increasing awareness regarding cancer is one of the pivotal factors accelerating market growth. Biopharmaceutical firms have reported the launch of public awareness campaigns for cancer. For instance, in May 2016 Roche launched a public awareness campaign known […]
The global depth filtration market is anticipated to showcase a considerable CAGR during the forecast period. The depth filter is a filter having no specified pore size or structure. Due to a random matrix or structure, it creates a tortuous path through the filter; in-depth filter particles are trapped or adsorbed both inside and on the filter. […]
Global amyotrophic lateral sclerosis treatment market is projected to grow at a considerable CAGR of 5.4% during the forecast period (2021-2027). According to the National Institute of Neurological Disorder and Stroke (NINDS), sporadic amyotrophic lateral sclerosis is the most common form type contributed to 90% of cases in the US and Familial amyotrophic lateral sclerosis […]
UK indapamide market is estimated to grow significantly at a CAGR of around 2.4% during the forecast period. A significant prevalence of CVDs has been witnessed in the country. According to the British Heart Foundation, more than one-fourth of the fatalities in UK occur due to CVDs, and it is responsible for around 1.6 million […]